Skip to main content

Table 3 Pre- and post-intervention total scores for the SEMCD and PROMIS-29v2 domains

From: Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program

Measure

Intervention N with data

Intervention mean (SD)

Control N with data

Control mean (SD)

SEMCD

 Baseline

26

5.0 (1.5)

14

4.8 (1.2)

 Month 3

23

5.8 (1.5)

12

5.6 (1.5)

PROMIS-29 v2.0 physical function

 Baseline

25

39.2 (8.10)

14

39.6 (9.9)

 Month 3

23

40.1 (8.9)

12

40.6 (9.4)

PROMIS-29 v2.0 anxiety

 Baseline

25

56.8 (8.7)

14

53.1 (9.1)

 Month 3

23

54.5 (10.3)

12

51.0 (8.5)

PROMIS-29 v2.0 depression

 Baseline

25

54.9 (9.5)

14

53.2 (9.0)

 Month 3

23

52.8 (10.3)

12

52.5 (8.0)

PROMIS-29 v2.0 fatigue

 Baseline

25

63.2 (8.1)

14

57.8 (11.8)

 Month 3

23

61.4 (9.7)

12

54.6 (9.1)

PROMIS-29 v2.0 sleep disturbance

 Baseline

25

55.4 (7.2)

14

52.4 (6.7)

 Month 3

23

55.5 (7.9)

12

53.6 (5.6)

PROMIS-29 v2.0 social roles

 Baseline

25

40.7 (5.9)

14

43.8 (11.5)

 Month 3

23

40.9 (8.1)

12

46.5 (7.6)

PROMIS-29 v2.0 pain interference

 Baseline

25

58.5 (7.0)

14

61.8 (7.8)

 Month 3

23

58.0 (8.2)

12

58.0 (7.7)

PROMIS-29 v2.0 pain intensity

 Baseline

25

4.8 (2.2)

14

4.9 (2.6)

 Month 3

23

4.1 (2.4)

12

5.2 (2.3)

  1. N number, PROMIS 29-item Patient-Reported Outcomes Measurement Information System, SEMCD Self-Efficacy for Managing Chronic Disease Scale, SD standard deviation